<DOC>
	<DOCNO>NCT02763033</DOCNO>
	<brief_summary>Investigators evaluate feasibility , safety early efficacy administer commercially available dietary supplement contain potato-based resistant starch subject undergo allogeneic SCT ( stem cell transplant ) . The intervention begin immediately prior condition phase continue day 100 . Investigators hypothesize short term administration resistant starch capable increase level butyrate within intestine reduce rate acute GVHD ( Graft-Versus-Host Disease ) .</brief_summary>
	<brief_title>Modification Intestinal Microbiome Diet Intervention Mitigate Acute Graft-Versus-Host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Subjects undergo match related full intensity allogeneic HSCT ( hematopoietic stem cell transplantation ) Age ≥ 18 year feasibility phase . Age ≥10 year old AND ≥50 kg phase II portion . Karnofsky &gt; 70 % , ( Karnofsky Performance Status : attempt quantify cancer patient ' general wellbeing activity daily life . The score range 0 100 100 `` perfect '' health 0 death . ) Subjects must able swallow capsules/tablets Ability understand willingness sign write informed consent . Availability HLA ( human leukocyte antigen ) match related donor . Patients inflammatory bowel disease . Patients history gastric bypass surgery . Patients active Clostridium difficile infection time study enrollment . Active infection define stool sample positive Clostridium difficile toxin via EIA ( enzyme immunoassay ) either symptom ( frequent loose stool ) OR image finding consistent toxic megacolon . Patients actively enrol GVHD prevention trial . Any physical psychological condition , opinion investigator , would post unacceptable risk patient raise concern patient would comply protocol procedure .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>